Given the burden of coronary artery disease (CAD), Prognostic Value of Coronary Artery Calcification CORONARY ARTERY CALCIFICATION

Size: px
Start display at page:

Download "Given the burden of coronary artery disease (CAD), Prognostic Value of Coronary Artery Calcification CORONARY ARTERY CALCIFICATION"

Transcription

1 Prognostic Value of Coronary Artery Calcification Matthew J. Budoff, MD Objective: The quantitation of coronary artery calcium using electron beam tomography (EBT) has been proposed as an early detection method. The objective of this paper is to summarize the known data about coronary artery calcium and event prediction with EBT and spiral computed tomography (CT). Design: Comprehensive review of the literature, including MEDLINE and abstracts from recent radiology and cardiology meetings. Data sources: 9 manuscripts involving EBT were identified, encompassing 6320 persons. There were no published prognostic studies of spiral CT. Outcome measure: Cardiac endpoints were described as hard (fatal or nonfatal myocardial infarction) and soft clinical events (revascularization). Results: The predictive ability of EBT for coronary artery disease events was studied in 3 manuscripts in symptomatic persons and in 6 manuscripts in asymptomatic persons. Summary risk for 3 studies of symptomatic populations (total, 1000 patients followed for an average of 3.5 years) demonstrated that EBT-derived calcium scores confer a 9.3-fold increased risk for cardiac events. Similarly, a composite of 6 studies of asymptomatic persons (5320 persons followed for 3.6 years) demonstrated a 10.9-fold increase risk of suffering a cardiac event. Conclusion: This ability to predict future cardiac events, in both symptomatic and asymptomatic persons, will potentially add to the ability of the medical community to identify high-risk individuals prior to the cardiovascular event. Larger and longer population studies in asymptomatic populations are underway. Given the burden of coronary artery disease (CAD), accounting for over 500,000 deaths annually, there is a need for new strategies for identifying high-risk individuals prior to the first event [1]. The initial manifestation of CAD in up to 50% of patients is a serious or lifeending event, such as sudden death or extensive myocardial infarction (MI) [2,3]. While lifestyle changes and certain pharmacological interventions have been shown to increase the life expectancy of high-risk persons [4], establishing an inexpensive and safe screening test that can accurately identify persons who have unrecognized CAD would be of enormous benefit. Unfortunately, many previous attempts at screening were directed at finding advanced luminal obstruction (eg, exercise treadmill testing, stress nuclear testing, stress echocardiography). Multiple trials have now demonstrated that a vast majority of heart attacks occur at the site of a nonobstructive plaque [5]. Coronary occlusion and MI most frequently evolve from mild to moderate stenoses [5 7]. This minimal stenosis can rupture, causing death or MI, in the absence of an advanced (highly stenotic) lesion in the coronary tree. Furthermore, research over the past decade has demonstrated that luminal obstruction is not the greatest predictor of cardiac events. Studies of patients dying from either acute MI or sudden cardiac death have also demonstrated that the extent of coronary atherosclerosis, rather than the severity of stenosis, is the most important predictor [8,9]. Thus, the need to measure coronary plaque burden, rather than stenosis severity (as seen on cardiac catheterization), has become paramount to risk stratification. Coronary Artery Calcification and Atherosclerosis Calcific deposits in coronary arteries are pathognomonic of atherosclerosis [10,11]. Histopathological [11,12,13] and intravascular ultrasound [14,15,16] studies confirm the close correlation between atherosclerotic plaque burden and extent of coronary artery calcification (CAC). Investigators measured plaque volume and demonstrated consistent and direct relations between CAC and plaque volume by autopsy and intravascular ultrasound. Electron beam tomography (EBT) can accurately and noninvasively quantitate the amount of CAC (r > 0.90) [17,18]. Other noninvasive modalities to diagnose CAD focus on physiological consequences of coronary obstruction, while EBT coronary calcium represents an anatomic measure of plaque burden [19]. Calcification and Plaque Rupture Although calcification is ubiquitous in complex coronary atherosclerotic plaques, calcium appears to be more than just From the Division of Cardiology, Saint John s Cardiovascular Research Center, Harbor-UCLA Medical Center Research and Education Institute, Torrance, CA. 42 JCOM November 2001 Vol. 8, No. 11

2 CLINICAL REVIEW an innocent bystander for the disease. It is associated with an increased risk of plaque rupture and thrombosis [20,21]. The presence of a soft plaque with a point of weakness adjacent to an area of calcification predisposes the plaque to rupture [22]. However, as the calcific and fibrotic plaque lesions are much stiffer than the softer cellular lesions, calcification may actually be an attempt by the arterial walls to stabilize themselves and thereby minimize the risk of plaque rupture. Thus, it may be that early or moderate arcs of calcification render a plaque more prone to rupture, whereas extensive concentric calcification (seen particularly in the very elderly), may render a plaque less likely to rupture [23]. Regardless of the ongoing debate as to the exact composition of the vulnerable plaque, CAC is almost always ubiquitous in patients who suffer cardiac events. Electron Beam Tomography Electron beam tomography cardiac imaging involves obtaining thin slices (each 3 mm) of the heart and coronary arteries to evaluate for CAC. Usually 30 to 40 axial images are obtained to include the full length of the myocardium. The entire coronary artery tree is imaged during a single 20- to 30-second breathhold. Rapid image acquisition (100 msec) prevents image blurring and allows accurate visualization of very small calcium deposits in the coronary arteries. The calcific deposits in the arterial walls demonstrate a high attenuation compared to the surrounding soft tissue, and this permits the easy identification of CAC without injection of contrast medium [24]. This speed of acquisition (temporal resolution) greatly differentiates EBT from the results of the slower images from spiral (or multislice helical) computed tomography (CT) [25,26]. The only studies demonstrating similar results between EBT and spiral CT included elderly symptomatic men with very high plaque burdens [27,28]. The differences at lower scores may very well prove a major difference in prognostic ability. Since there is no improvement of temporal resolution with newer multislice CT scanners (each slice is still obtained in 250 to 330 msec), it is unlikely that closer correlations with EBT will be obtained. Furthermore, with thinner slices being obtained, more radiation is given to the patient, potentially increasing radiation doses to the patient with multislice CT by 6 to 38 times over EBT [29]. Only the long-term studies now underway (such as the ongoing Multiethnic Study of Atherosclerosis) will be able to demonstrate whether spiral CT has a role in prognostication. Calcification and Cardiac Risk in the Symptomatic Cohort Numerous studies demonstrate that the calcium detected by EBT is a marker of the total atherosclerotic burden, and the extent of coronary atheromatous disease remains the most powerful predictor of subsequent or recurrent cardiac events [30,31]. While useful for use in the symptomatic population to determine the presence and severity of obstructive disease [24,32], the most important data for this modality relates to its ability to predict future coronary events in both symptomatic and asymptomatic persons. The need for a screening test for early atherosclerosis is in part due to the failure of risk factors to predict cardiac events. Risk factors have been demonstrated to be poor predictors of future events, failing to predict one-third of future deaths due to coronary heart disease [33]. In a study of symptomatic patients by Kennedy et al [34], EBT-detected coronary calcium was a stronger independent predictor of disease and future events than a sum of all of the traditional risk factors combined. This paper evaluated the published data to identify the prognostic ability of EBT. A comprehensive review of the literature, including MEDLINE and abstracts from recent radiology and cardiology meetings, was performed. Nine manuscripts involving EBT were identified, encompassing 6320 persons. Three studies involved symptomatic persons [35 37] and 6 studies involved asymptomatic persons [38 43]. CAC appears to be a far more powerful risk factor for coronary events than any other known risk factor [38]. Margolis and colleagues in 1980 found that patients referred for cardiac catheterization with coronary calcium on conventional fluoroscopy had a 5-year survival rate of 58% versus 87% in patients without detectable calcium [20]. This was independent of age, gender, and angiographically diseased vessels. Detrano et al s multicenter study [35] of 491 patients undergoing coronary angiography and EBT scanning found that higher calcium scores were associated with an increased risk of coronary events over the next 30 months. This study found an event rate increase 10 times higher in patients with calcium scores over the 75 th percentile as compared to those below the 25 th percentile (odds ratio [OR], 10.8 [95% confidence interval {CI}, 1.4 to 85.6]). Logistic regression including gender, age, calcium score, and angiographically diseased vessels showed that only EBT calcium score predicted events. This study demonstrated that 86% of the events occurred in patients whose scores were 100 or greater, with significantly greater event-free survival in patients with lower scores (P = 0.009). The ability to predict future events was greater with EBT calcium scores than with measures of angiographic severity, reinforcing the idea that plaque burden, and not stenosis severity, is a more important marker of disease [6]. Keelan et al [36] followed 288 symptomatic persons who underwent angiography and EBT calcium scanning for a mean of 6.9 years. Event-freesurvival was significantly higher for patients with CAC scores less than 100 than it was for those with scores greater than 100 (relative risk [RR] 3.2 [95% CI, 1.2 to 8.7]) and above the median score (RR, 3.4 [CI, 1.3 to 8.7]). In the final stepwise Cox proportional hazards model that included risk factors, CAD event history; CAC measures; and angiographic measures of disease, age, and log-transformed Vol. 8, No. 11 November 2001 JCOM 43

3 Table 1. Characteristics and Risk Ratios for Follow-up Studies in Symptomatic Populations Follow-up Cutoff for Risk Author Number % Male Mean Age, Yr Duration, Mo Assessment Risk Ratio Weight, % Detrano [35] Top quartile Keelan [36] Median (> 480 CAC) Georgiou [37] Median* TOTAL CAC = coronary artery calcification score. *Using age- and gender-matched cohorts representing scores above the median. CAC score were the only independent predictors of future hard coronary events. Importantly, no conventional coronary risk factors other than age predicted events. While the study demonstrated that plaque burden by EBT was associated with increased cardiovascular risk over 7 years, the study was limited by its patient population. However, this study confirmed the previous findings of Detranoet al [35], which showed that CAC extent determined by EBT provides more prognostic information than angiography in symptomatic patients. This phenomenon is most likely due to the remodeling phenomenon, in which vessel wall enlargement compensates for increasing plaque volume [44]. However, CAC extent is unaffected by remodeling, and as the overall disease burden and the likelihood of vulnerable plaque increase, so does CAC extent [45]. Another recent study [37] reported a 50-month mean follow-up of a chest pain population. Cox proportional hazards regression showed CAC to be associated with a greater risk for having a new cardiovascular event independent of age, gender, race, and other risk factors. Those with any CAC had an increased risk of new cardiovascular events (OR, 27.8 [95% CI, 1.88,815]; P = 0.02). Multivariate logistic regression analysis demonstrated CAC score and age- and gender-matched calcium percentiles to be the strongest predictors of future events. The summary risk ratio for a combined coronary event (eg, death, MI, or revascularization) was 9.3 in these studies of symptomatic persons (Table 1). This represents 3 studies including 1000 persons, followed for an average of 42 months. EBT outperformed angiography and all risk factors in event prediction in all studies in which both were tested. Risk Prediction in the Asymptomatic Population The potential utility of any screening tool is greatest in the asymptomatic (primary prevention) population. Determining where to apply more aggressive therapies, including cholesterol reduction, antiplatelet therapy, diet, and exercise, is of greatest interest to the preventive health community. With the recent withdrawal from the marketplace of 1 of the statin medications due to safety concerns (cerivastatin), the need to identify persons who would benefit from these medications is even greater. While the short- and long-term risks of the statins have been shown to be minimal overall [46], targeting therapy to those who will benefit will clearly improve any risk or cost profile for this therapy. Similarly, if a high-risk population can be identified by a screening test, further evaluation to find and treat modifiable risk factors could be implemented, potentially including further lipoprotein analysis, C-reactive protein, homocysteine, and many other potentially modifiable factors. Several studies of CAC have been performed in the asymptomatic population. The first reported a 19-month follow-up of 1289 asymptomatic patients and found a 6.9-fold increase of hard events (MI and cardiac death) in patients with calcium scores over 50 compared to those with negative or lower scores [47]. Arad et al [48] initially reported a 19-month follow-up of 1173 patients over 19 months, finding CAC to be the strongest predictor of future cardiac events. This prospective study now has been carried out for a total of 3.6 years of follow-up, maintaining the strong power of this technology to predict future cardiac events [38]. During this 3.6-year follow-up period, 39 patients suffered coronary events. The mean CAC score was 764 among subjects with events as compared to 135 among those without events (P < 0.001). Patients with EBT scores above 80 were 22 times more likely to suffer an MI or death over the follow-up period (OR, 22.3 [CI, 5.1 to 97.4]). The odds ratio of suffering a coronary event remained high (14.3 to 20.2) after adjustment for cardiovascular risk factors. The longest follow-up data available are from Agatston et al, in which 367 patients were followed up to 6 years. Agatston noted a significant difference in the mean coronary calcium scores for patients with cardiac events (399 ± 424), versus those without cardiac events (76 ± 207) [39]. This difference was computed to an odds ratio of 21.2 for coronary events in patients with CAC scores greater than 26, and 16.9 for scores above 50 (hard events). It should be noted that caution should be used in screening an older population. Our group published an analysis in an older population (1196 patients, 89% male, mean age 66 years) [40]. This study demonstrated that while coronary 44 JCOM November 2001 Vol. 8, No. 11

4 CLINICAL REVIEW calcium was a significant predictor of future cardiac events, it did not have great power over traditional risk factors to discriminate who would develop CAD events. The composite endpoint of coronary death or infarction was significantly higher in the upper tertiles of the calcium score (P < 0.01). In this study, neither traditional risk factors nor EBT coronary calcium accurately predicted future events. We identified several factors that limited our study. First, our study sample was very homogenous, mostly elderly men with hypertension and/or diabetes. Secondly, we utilized a minimum area for calcification that was much larger (16 times) than other studies, requiring a very large focus of calcification to qualify as a lesion. It is likely that smaller plaques can be destabilizing and large areas of calcification protective. Finally, we utilized a scanning protocol (6 mm thick slices) that has proven to be not as sensitive as the standard protocol (3 mm) [49]. However, in this study, among of the population most likely to benefit from screening for heart disease (ages 45 to 62 years) the relative risk of developing a cardiac event was 6.3 (P < 0.001) [50]. Thus, performing the study properly and targeting of the correct population is of great importance when applying this test. Secci [51] reported a subset study of 326 patients, with 8 of 9 hard events and 20 of 21 total cardiac events (hard events and revascularization) occurring in those patients with EBT calcium scores over 15 (P < 0.001), demonstrating excellent prognostic ability. A meta-analysis [52] of 5 studies (2 abstracts and 3 manuscripts) [53] involving 4348 subjects found that a calcium score above a median score was associated with an increased risk of a combined outcome of nonfatal infarction, death, or revascularization (risk ratio, 8.7 [95% CI, 2.7 to 28.1]) and of a hard event (eg, death or infarction [risk ratio 4.2 {95% CI, 1.6 to 11.3}]). The authors concluded that there exists a moderate to strong association between coronary calcification as detected by EBT and hard and soft coronary outcomes. In a recent study of 676 asymptomatic patients (mean age, 52 years; 51% men) prospectively followed for 32 ± 7 months by Raggi et al [41], calcium scores outperformed risk factors in cardiac event prediction and demonstrated the incremental benefit of adding calcium scores to conventional risk factors. Multiple logistic regression analyses demonstrated that calcium score (adjusted for age) was the only significant predictor of events and provided incremental prognostic value when added to traditional risk factors for CAD (chi-square, P < 0.001). In a comparison of receiver-operator characteristic curves for prediction of hard events, the area under the curve for calcium score percentile plus conventional risk factors and age was significantly larger than that obtained by use of traditional risk factors and age separately as predictors (0.84 versus 0.71, respectively; P < 0.001). Furthermore, the area under the curve of calcium scores alone was significantly larger than that of traditional risk factors and age combined (0.82 versus 0.71; P = 0.028). Increasing age- and gender-matched scores were even more predictive. Thus, patients with scores above the median had an odds ratio of 5.5 (3.0 to 10.1) for fatal and nonfatal MI. The risk increased with increasing scores, and for patients with scores above the 90th percentile (as compared to age- and gender-matched peers), the odds ratio increased to 21.6 (7.3 to 64.1). The authors concluded that an age- and sex-specific calcium score provides the best predictive model for the occurrence of hard coronary events and adds incremental prognostic information to conventional risk factors for CAD. Similarly, in a recent publication by Wong et al [42], 928 asymptomatic men and women (mean age, 54 years) followed for an average of 3.3 years with an absolute CAC score in the upper 3rd and 4th quartiles showed a relative risk for cardiovascular events of 4.5 and 8.8 times that of patients in the lowest quartile, respectively. With use of Cox proportional-hazards, it was shown that patients with CAC had a greater risk of events than patients without CAC independent of age, sex, and risk factors. The summary risk ratio for a combined coronary event (death, MI, or revascularization) was 10.7 in these studies of asymptomatic persons (Table 2). This represents 6 studies including 5320 persons, followed for an average of 43 months. EBT outperformed risk factors and other demographic variables for event prediction in all studies, except for the study of elderly persons by Detrano et al [40]. Comparisons with Other Screening Tests and Implications for Risk Stratification To put these figures in perspective, screening stress tests predict future cardiac events with an odds ratio of 1 to 3 at 6 years [38]. Cholesterol values, hypertension, diabetes, and other Framingham risk factors have been reported to be associated with odds ratios of 1 to 3 for future cardiac events [54]. C-reactive protein, a marker of inflammation, demonstrated an odds ratio of 2 to 4.4 for predicting future cardiac events [55]. Thus, with an odds ratio of 4.2 to 22, EBT-detected CAC appears to be a more comprehensive measure of future cardiac risk. The importance of finding new predictors of risk is highlighted by the known suboptimal predictive value of conventional risk factors. Despite the use of a multifactorial approach to risk stratification, as advocated in the Framingham study and the National Cholesterol Education Program guidelines, more than 50% of the hard coronary events remain unpredictable and occur in patients at intermediate risk [56]. Furthermore, compliance and patient behavior can be positively modified using this technology. Demonstrating to patients that they have atherosclerosis makes them more likely to become health conscious and increases their adherence to medical therapies. Wong et al [57] demonstrated that Vol. 8, No. 11 November 2001 JCOM 45

5 Table 2. Characteristics and Risk Ratios for Follow-Up Studies in Asymptomatic Populations Follow-up Cutoff for Risk Author Number % Male Mean Age, Yr Duration, Mo Assessment Risk Ratio Weight, % Arad [38] CAC > Detrano [40] CAC > Raggi [41] Top quintile* Agatston [39] CAC > Sullivan [43] Top quartile Wong [42] CAC > (top quartile) TOTAL CAC = coronary artery calcification score. *Using age- and gender-matched cohorts representing the top quintile. Using age- and gender-matched cohorts representing the top quartile. persons with CAC have been reported to be more likely to undertake preventive health measures, including beginning cholesterol- or blood pressure-lowering medications, starting aspirin, beginning an exercise program, following a lowfat diet, or quitting smoking. The use of EBT to better risk stratify patients could greatly reduce costs and better direct therapy. In preventive medicine, a primary aim is to match intensity of therapy (eg, lipid lowering, antiplatelet) with absolute risk. Because drug therapy entails signficant expense, choosing high-risk individuals for more aggressive therapy is the paradigm for every prevention cohort. The average cost of statin therapy in the United States is approximately $720 per year [58], not including physician visits or laboratory tests. The clinician must accurately identify those persons who would most likely benefit from this costly but potentially lifesaving therapy. In 1 model of cost-effectiveness, coronary artery screening with EBT was demonstrated to be a cost-effective screening test in asymptomatic individuals between 45 and 65 years of age, particularly if they are at increased risk of coronary events [59]. Combining the power of this noninvasive tool with the effectiveness of statin drugs and aspirin will allow physicians to focus aggressive preventative treatment on those individuals with underlying atherosclerosis who are at highest risk for having future heart attacks and coronary death. Prospective evaluation of this model is currently underway in a large population-based study. Since results are 7 years away, physicians should consider applying aspirin and cholesterolreduction to those patients with detectable CAC in the interim. It is also obvious that the absence of CAC on coronary screening, even in the presence of risk factors, identifies a group of patients at very low risk of events over the next 3 to 5 years. Both the American College of Cardiology/American Heart Association writing group and the Prevention V Conference agreed that the negative predictive value of EBT is very high for short-term events [60,61]. Caution in the widespread application of EBT has been voiced [61]. Direct patient advertising without physician interaction, inappropriate cardiac catheterization after detection of coronary calcification in asymptomatic persons, and limited data on cost-effectiveness have been deemed the largest shortcomings in this technology. Physicians must remember that detection of coronary calcium, especially in asymptomatic persons, generally should not lead to cardiac catheterization. The risk of obstruction on angiography with scores less than 400 are minimal [45]. Rather, a positive EBT should be considered indicative that there exists advanced atherosclerosis, and appropriate therapies should be applied [45,60,61]. Summary Every study reported to date using EBT suggests a strong association between CAC and hard and soft coronary outcomes. The presence of CAC in asymptomatic individuals predicts the occurrence of acute coronary events with greater accuracy than other screening tests, including Framingham risk factors [34,38,41,42,50]. The use of this tool in further risk-stratifying intermediate- and high-risk asymptomatic persons is probably warranted based upon the available literature. Data using multislice spiral CT is not available, and this modality should not be used as a surrogate for EBT until more data is available. Corresponding author: Matthew J. Budoff, MD, Harbor-UCLA Medical Center, 1124 W. Carson Street, RB2, Torrance, CA 90502, mbudoff@rei.edu. Financial disclosures: Dr. Budoff is a member of the Speakers Bureau, Imatron, manufacturer of EBT scanners. 46 JCOM November 2001 Vol. 8, No. 11

6 CLINICAL REVIEW References 1. American Heart Association. Heart and stroke facts. Dallas: American Heart Association; Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 1985;5:141B 149B. 3. Brush JE Jr, Brand DA, Acampora D, et al. Relation of peak creatine kinase levels during acute myocardial infarction to presence or absence of previous manifestations of myocardial ischemia (angina pectoris or healed myocardial infarction). Am J Cardiol 1988;62: Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333: Giroud D, Li JM, Urban P, et al. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992;69: Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78(5 pt 1): Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol 1979;44: Roberts WC, Jones AA. Quantification of coronary arterial narrowing at necropsy in acute transmural myocardial infarction. Analysis and comparison of findings in 27 patients and 22 controls. Circulation 1980;61: Rifkin RD, Parisi AF, Folland E. Coronary calcification in the diagnosis of coronary artery disease. Am J Cardiol 1979;44: McCarthy JH, Palmer FJ. Incidence and significance of coronary artery calcification. Br Heart J 1974;36: Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relation to atherosclerosis and myocardial infarction. Am J Roentgenol 1964;92: Eggen DA, Strong JP, McGill HC Jr. Coronary calcification. Relationship to clinically significant coronary lesions and race, sex, and topographic distribution. Circulation 1965:32; Schmermund A, Baumgart D, Goerge G, et al. Coronary artery calcium in acute coronary syndromes: a comparative study of electron-beam computed tomography, coronary angiography, and intracoronary ultrasound in survivors of acute myocardial infarction and unstable angina. Circulation 1997;96: Mintz GS, Pichard AD, Popma JJ, et al. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol 1997;29: Baumgart D, Schmermund A, Goerge G, et al. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis. J Am Coll Cardiol 1997;30: Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;92: Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998;31: Mautner SL, Mautner GC, Froehlich J, et al. Coronary artery disease: prediction with in vitro electron beam CT. Radiology 1994;192: Margolis JR, Chen JT, Kong Y, et al. The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. Radiology 1980;137: Detrano RC, Wong ND, Tang W, et al. Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in asymptomatic high risk subjects. J Am Coll Cardiol 1994; 24: Sharma SK, Israel DH, Kamean JL, et al. Clinical, angiographic, and procedural determinants of major and minor coronary dissection during angioplasty. Am Heart J 1993; 126: Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 1992; 86: Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation 1996;93: Budoff MJ, Mao S, Zalace CP, et al. Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons. Int J Cardiol 2001;77: Goldin JG, Yoon HC, Greaser LE 3rd, et al. Spiral versus electron-beam CT for coronary artery calcium scoring. Radiology 2001;221: Becker CR, Knez A, Ohnesorge B, et al. Visualization and quantification of coronary calcifications with electron beam and spiral computed tomography. Eur Radiol 2000;10: Carr JJ, Crouse JR 3rd, Goff DC Jr, et al. Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. Am J Roentgenol 2000;174: Hidajat N, Wolf M, Rademaker J, et al. Radiation dose in CT of the heart for coronary heart disease and CT of the lung for pulmonary embolism. Comparisons between single-slice detector CT, multi-slice detector CT and EBT. Radiology 2000; 217: Hasdai D, Bell MR, Grill DE, et al. Outcome > or = 10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol 1997;79: Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982;66: Shavelle DM, Budoff MJ, LaMont DH, et al. Exercise testing and electron beam computed tomography in the evaluation Vol. 8, No. 11 November 2001 JCOM 47

7 of coronary artery disease. J Am Coll Cardiol 2000;36: Grover SA, Coupal L, Hu XP. Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? JAMA 1995;274: Kennedy J, Shavelle R, Wang S, et al. Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J 1998;135: Detrano R, Hsiai T, Wang S, et al. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol 1996;27: Keelan PC, Bielak LF, Ashai K, et al. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 2001;104: Georgiou D, Budoff MJ, Kaufer E, et al. Screening patients with chest pain in the emergency department using electron beam tomography: a follow-up study. J Am Coll Cardiol 2001;38: Arad Y, Sparado LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000;36: Agatston AS, Janowitz WR, Kaplan GS, et al. Electron beam CT predicts future coronary events (abstract). Circulation 1996;94(Suppl 1):1 360(abstract). 40. Detrano RC, Wong ND, Doherty TM, et al. Coronary calcium does not accurately predict near-term future cardiac events in high-risk adults [published errata appear in Circulation 2000;101:697 and 2000;101:1355]. Circulation 1999:99: Raggi P, Cooil B, Callister TQ. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J 2001;141: Wong ND, Hsu JC, Detrano RC, et al. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 2000; 86: Sullivan CJ, Fisher BT, Bagai J, et al. Coronary artery calcium screening by electron beam computed tomography: a 4-year follow-up for coronary events [abstract]. Circulation 1998; 98:I Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92: Rumberger JA, Brundage BH, Rader DJ, et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons [published erratum appears in Mayo Clin Proc 1999;74:538]. Mayo Clin Proc 1999;74: Bottorff M, Hansten P. Long-term safety of heaptic hydroxmethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians. Arch Intern Med 2000;160: Detrano R, Schwendener C, Doherty T, Secci A. Coronary calcium results predict coronary heart disease deaths in high risk asymptomatic adults. J Am Coll Cardiol 1997;29:128A. 48. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93: Callister TQ, Janowitz W, Raggi P. Sensitivity of two electron beam tomography protocols for the detection and quantification of coronary artery calcium. Am J Roentgenol 2000; 175: Detrano RC, Tang W, Wong ND, et al. Does age affect the accuracy of coronary calcium for predicting coronary events? J Am Coll Cardiol 1999;33:415A. 51. Secci A, Wong N, Tang W, et al. Electron beam computed tomographic coronary calcium as a predictor of coronary events: comparison of two protocols. Circulation 1997;96: O Malley PG, Taylor AJ, Jackson JL, et al. Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol 2000;85: Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101: Uhl GS, Froelicher V. Screening for asymptomatic coronary artery disease. J Am Coll Cardiol 1983;1: Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: Pitt B, Rubenfire M. Risk stratification for the detection of preclinical coronary artery disease. Circulation 1999;99: Wong ND, Detrano RC, Diamond G, et al. Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol 1996;78: Manson JE, Tosteson H, Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med 1992;326: Rumberger JA, Behrenbeck T, Breen JF, Sheedy PF 2nd. Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: a model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods. J Am Coll Cardiol 1999; 33: Smith SC Jr, Greenland P, Grundy SM. AHA conference proceedings. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation 2000;101: O Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000;36: Copyright 2001 by Turner White Communications Inc., Wayne, PA. All rights reserved. 48 JCOM November 2001 Vol. 8, No. 11

Diagnostic and Prognostic Value of Coronary Ca Score

Diagnostic and Prognostic Value of Coronary Ca Score Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium

More information

Coronary Artery Calcification

Coronary Artery Calcification Coronary Artery Calcification Julianna M. Czum, MD OBJECTIVES CORONARY ARTERY CALCIFICATION Julianna M. Czum, MD Dartmouth-Hitchcock Medical Center 1. To review the clinical significance of coronary heart

More information

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017 Coronary Artery Calcification Dharmendra A. Patel, MD MPH Director, Echocardiography Laboratory Associate Program Director Cardiovascular Disease Fellowship Program Erlanger Heart and Lung Institute UT

More information

Although the burden of cardiovascular disease. Prognostic Value of Coronary Artery Calcium Screening. CLinical review

Although the burden of cardiovascular disease. Prognostic Value of Coronary Artery Calcium Screening. CLinical review CLinical review Prognostic Value of Coronary Artery Calcium Screening Nove K. Kalia, MD, and Matthew J. Budoff, MD Abstract Objective: To summarize the known data about coronary artery calcium (CAC) scoring

More information

Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events

Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events A 37-Month Follow-Up of 5635 Initially Asymptomatic Low- to Intermediate- Adults George T. Kondos, MD; Julie Anne Hoff, PhD, RN; Alexander

More information

Coronary Artery Calcium Score and Coronary Heart Disease Events in a Large Cohort of Asymptomatic Men and Women

Coronary Artery Calcium Score and Coronary Heart Disease Events in a Large Cohort of Asymptomatic Men and Women American Journal of Epidemiology Copyright ª 2005 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 162, No. 5 Printed in U.S.A. DOI: 10.1093/aje/kwi228 Coronary Artery Calcium

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

Coronary artery disease (CAD) is the leading

Coronary artery disease (CAD) is the leading C l i n i c a l R e v i e w A r t i c l e Role of Electron Beam Computed Tomography in Detecting and Assessing Coronary Artery Disease Amber M. Shah, MD, MPH Adam H. Feldman, MD, MPH David L. George, MD

More information

Coronary Artery Calcium to Predict All-Cause Mortality in Elderly Men and Women

Coronary Artery Calcium to Predict All-Cause Mortality in Elderly Men and Women Journal of the American College of Cardiology Vol. 52, No. 1, 28 28 by the American College of Cardiology Foundation ISSN 735-197/8/$34. Published by Elsevier Inc. doi:1.116/j.jacc.28.4.4 CLINICAL RESEARCH

More information

High Coronary Artery Calcium Scores Pose an Extremely Elevated Risk for Hard Events

High Coronary Artery Calcium Scores Pose an Extremely Elevated Risk for Hard Events Journal of the American College of Cardiology Vol. 39, No. 2, 2002 2002 by the American College of Cardiology ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(01)01737-5 High

More information

Coronary artery disease

Coronary artery disease Bruce B. Forster, MD, FRCPC, Saul Isserow, MD, FRCPC Coronary artery calcification and subclinical atherosclerosis: What s the score? A CT scan assessment of the total burden of coronary atherosclerosis

More information

Coronary artery calcium screening: implications for clinical practice

Coronary artery calcium screening: implications for clinical practice For reprint orders, please contact: reprints@futuremedicine.com REVIEW Coronary artery calcium screening: implications for clinical practice E Ferramosca, MD, A Bellasi, MD, Carlo Ratti, MD, Paolo Raggi,

More information

Kumar S, Sharma S. Department of Cardiac Radiology, AIIMS, New Delhi, India

Kumar S, Sharma S. Department of Cardiac Radiology, AIIMS, New Delhi, India REVIEW ARTICLE Coronary Artery Calcium Scoring by Cardiac CT as A Screening Tool in 40-45 Years Age Group Predictor of Future Risk for Cardiovascular Events- Systemic Review Kumar S, Sharma S Department

More information

Cardiac CT Angiography

Cardiac CT Angiography Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis

More information

M Marwan, D Ropers, T Pflederer, W G Daniel, S Achenbach

M Marwan, D Ropers, T Pflederer, W G Daniel, S Achenbach Department of Cardiology, University of Erlangen, Erlangen, Germany Correspondence to: Dr M Marwan, Innere Medizin II, Ulmenweg 18, 91054 Erlangen, Germany; mohamed.marwan@ uk-erlangen.de Accepted 17 November

More information

Journal of the American College of Cardiology Vol. 36, No. 1, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 36, No. 1, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 36, No. 1, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00680-X Lack

More information

Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles

Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles Journal of the American College of Cardiology Vol. 53, No. 4, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.07.072

More information

Effective for dates of service on or after April 1, 2013, refer to:

Effective for dates of service on or after April 1, 2013, refer to: Effective for dates of service on or after April 1, 2013, refer to: https://www.bcbsal.org/providers/policies/carecore.cfm Name of Policy: Computed Tomography to Detect Coronary Artery Calcification Policy

More information

Coronary Artery Calcium Score

Coronary Artery Calcium Score Coronary Artery Calcium Score August 19, 2014 by Axel F. Sigurdsson MD 174 Comments essential for living organisms. Calcium is a chemical element that is Most of the calcium within the human body is found

More information

Title for Paragraph Format Slide

Title for Paragraph Format Slide Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38

More information

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

More information

Electron Beam Computed Tomographic Coronary Calcium Score Cutpoints and Severity of Associated Angiographic Lumen Stenosis

Electron Beam Computed Tomographic Coronary Calcium Score Cutpoints and Severity of Associated Angiographic Lumen Stenosis 1542 JACC Vol. 29, No. 7 CORONARY ARTERY DISEASE Electron Beam Computed Tomographic Coronary Calcium Score Cutpoints and Severity of Associated Angiographic Lumen Stenosis JOHN A. RUMBERGER, PHD, MD, FACC,

More information

Medical Policy Electron Beam CT for Detection of Coronary Artery Disease

Medical Policy Electron Beam CT for Detection of Coronary Artery Disease Effective Date: May 3, 2017 Medical Policy Electron Beam CT for Detection of Coronary Artery Disease Subject: Electron Beam Computed Tomography for Detection of Coronary Artery Disease Background: Electron

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

Study of estimation of coronary artery calcium by multi-slice spiral CT scan in post myocardial infarction cases

Study of estimation of coronary artery calcium by multi-slice spiral CT scan in post myocardial infarction cases International Journal of Advances in Medicine Gosavi RV et al. Int J Adv Med. 2017 Oct;4(5):1293-1298 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20173730

More information

Prognostic Value of Cardiac Risk Factors and Coronary Artery Calcium Screening for All-Cause Mortality 1

Prognostic Value of Cardiac Risk Factors and Coronary Artery Calcium Screening for All-Cause Mortality 1 Cardiac Imaging Radiology Leslee J. Shaw, PhD Paolo Raggi, MD Enrique Schisterman, PhD Daniel S. Berman, MD Tracy Q. Callister, MD Index terms: Computed tomography (CT), electron beam, 54.1211 Coronary

More information

Screening for Cardiovascular Risk (2/6/09)

Screening for Cardiovascular Risk (2/6/09) Screening for Cardiovascular Risk (2/6/09) Andrew Nicolaides MS, FRCS, FRCSE, PhD (Hon) Emeritus Professor of Vascular Surgery, Imperial College, London, UK Chairman, Cardiovascular Disease Educational

More information

Despite the availability of effective preventive therapies,

Despite the availability of effective preventive therapies, Combined Use of Computed Tomography Coronary Calcium Scores and C-Reactive Protein Levels in Predicting Cardiovascular Events in Nondiabetic Individuals Robert Park, MD; Robert Detrano, MD, PhD; Min Xiang,

More information

Utility of Coronary Artery Calcium Measurement In Cardiovascular disease. California Technology Assessment Forum

Utility of Coronary Artery Calcium Measurement In Cardiovascular disease. California Technology Assessment Forum TITLE: Utility of Coronary Artery Calcium Measurement In Cardiovascular disease AUTHOR: Jeffrey A. Tice, M.D. Assistant Adjunct Professor of Medicine Division of General Internal Medicine University of

More information

Coronary heart disease remains the number one

Coronary heart disease remains the number one This reprint is distributed as a professional courtesy by [matron, Inc. is offered by the American Heart Association solely for educational or training purposes, and does not constitute an endorsement

More information

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O. Using Coronary Artery Calcium Score in the Quest for Cardiac Health Robert J. Hage, D.O. Heart disease is the leading cause of death in the United States in both men and women. About 610,000 people die

More information

Calcium is a chemical element that is essential for living organisms.

Calcium is a chemical element that is essential for living organisms. 1 of 8 9/28/2015 9:04 AM Home About me Health and Nutrition Diet General Health Heart Disease August 19, 2014 By Axel F. Sigurdsson MD 259 Comments Like Share 82 Calcium is a chemical element that is essential

More information

Anatomy is Destiny, But Physiology is Here Today

Anatomy is Destiny, But Physiology is Here Today Published on Journal of Invasive Cardiology (http://www.invasivecardiology.com) September, 2010 [1] Anatomy is Destiny, But Physiology is Here Today Thu, 9/9/10-10:54am 0 Comments Section: Commentary Issue

More information

ACC/AHA Expert Consensus Document

ACC/AHA Expert Consensus Document ACC/AHA Expert Consensus Document American College of Cardiology/American Heart Association Expert Consensus Document on Electron-Beam Computed Tomography for the Diagnosis and Prognosis of Coronary Artery

More information

Electron Beam CT versus 16-slice Spiral CT: How Accurately Can We Measure. Coronary Artery Calcium Volume?

Electron Beam CT versus 16-slice Spiral CT: How Accurately Can We Measure. Coronary Artery Calcium Volume? Electron Beam CT versus 16-slice Spiral CT: How Accurately Can We Measure Coronary Artery Calcium Volume? 1 Objective: The purpose of this study is to investigate how accurately we can measure CAC volume

More information

Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm

Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm Mark J. Sands, MD Vice Chairman, Imaging Institute Clinical Operations and Quality Objectives Review of available radiologic

More information

European Journal of Radiology

European Journal of Radiology European Journal of Radiology 82 (2013) e58 e63 Contents lists available at SciVerse ScienceDirect European Journal of Radiology journa l h o me pa ge: www.elsevier.com/locate/ejrad Calcium score of small

More information

Setting The setting was the Walter Reed Army Medical Center. The economic study was carried out in the USA.

Setting The setting was the Walter Reed Army Medical Center. The economic study was carried out in the USA. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project

More information

New Paradigms in Predicting CVD Risk

New Paradigms in Predicting CVD Risk New Paradigms in Predicting CVD Risk Imaging as an Integrator of Lifetime Risk Exposure Michael J. Blaha MD MPH Presented by: Michael J. Blaha September 24, 2014 1 Talk Outline Risk factors vs. Disease

More information

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Quanta Diagnostico Nuclear Curitiba, Brazil Clinical history Male 63 y.o.,

More information

A Business Case for Early Detection of Cardiovascular Disease

A Business Case for Early Detection of Cardiovascular Disease HealthGroup W E S T Advisors to Cardiovascular Management A Business Case for Early Detection of Cardiovascular Disease The financial impact of current trends in population screening programs HealthGroup

More information

Disclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software

Disclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software CORONARY CALCIUM SCORING REVISITED Disclosures Consultant for M2S, Inc. Julianna M. Czum, MD Director, Division of Cardiothoracic Imaging Department of Radiology Dartmouth Hitchcock Medical Center Assistant

More information

Role of Nonenhanced Multidetector CT Coronary Artery Calcium Testing in Asymptomatic and Symptomatic Individuals 1

Role of Nonenhanced Multidetector CT Coronary Artery Calcium Testing in Asymptomatic and Symptomatic Individuals 1 Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Role of Nonenhanced

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

Is computed tomography angiography really useful in. of coronary artery disease?

Is computed tomography angiography really useful in. of coronary artery disease? Is computed tomography angiography really useful in screening patients with high risk of coronary artery disease? Myeong-Ki Hong, M.D. Ph D Professor of Medicine Division of Cardiology, Severance Cardiovascular

More information

Journal of the American College of Cardiology Vol. 46, No. 1, by the American College of Cardiology Foundation ISSN /05/$30.

Journal of the American College of Cardiology Vol. 46, No. 1, by the American College of Cardiology Foundation ISSN /05/$30. Journal of the American College of Cardiology Vol. 46, No. 1, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.02.088

More information

Electron Beam Computed Tomographic Coronary Calcium Scanning: A Review and Guidelines for Use in Asymptomatic Persons

Electron Beam Computed Tomographic Coronary Calcium Scanning: A Review and Guidelines for Use in Asymptomatic Persons pagina 1 van 11 Search the Journal search Advanced Search > Home Current Issue Past Issues Reprints Submissions Subscriptions Permissions About Us MAYO CLIN PROC. 1999;74:243-252 1999 MAYO FOUNDATION FOR

More information

Objective Calcium score carotid IMT hs-crp

Objective Calcium score carotid IMT hs-crp P3952 Role of coronary calcium score, carotid intima-media thickness and C-reactive protein in predicting extent of coronary artery disease in young patients. Bedside Poster P3952 Role of coronary calcium

More information

ORIGINAL INVESTIGATION. Using the Coronary Artery Calcium Score to Predict Coronary Heart Disease Events

ORIGINAL INVESTIGATION. Using the Coronary Artery Calcium Score to Predict Coronary Heart Disease Events Using the Coronary Artery Calcium Score to Predict Coronary Heart Disease Events A Systematic Review and Meta-analysis ORIGINAL INVESTIGATION Mark J. Pletcher, MD, MPH; Jeffrey A. Tice, MD; Michael Pignone,

More information

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2

More information

Value of Coronary Artery Calcium Scanning by Computed Tomography for Predicting Coronary Heart Disease in Diabetic Subjects

Value of Coronary Artery Calcium Scanning by Computed Tomography for Predicting Coronary Heart Disease in Diabetic Subjects Pathophysiology/Complications O R I G I N A L A R T I C L E Value of Coronary Artery Calcium Scanning by Computed Tomography for Predicting Coronary Heart Disease in Diabetic Subjects WENCHUN QU, MS 1

More information

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Alexandre C Ferreira, MD Clinical Chief of Cardiology Jackson Health System Director, Interventional Cardiology Training

More information

Although coronary atherosclerosis is the leading cause of

Although coronary atherosclerosis is the leading cause of Coronary Calcium Does Not Accurately Predict Near-Term Future Coronary Events in High-Risk Adults Robert C. Detrano, MD, PhD; Nathan D. Wong, PhD; Terence M. Doherty, BA; Robert M. Shavelle, PhD; Weiyi

More information

Computed Tomography to Detect Coronary Artery Calcification. Original Policy Date

Computed Tomography to Detect Coronary Artery Calcification. Original Policy Date MP 6.01.02 Computed Tomography to Detect Coronary Artery Calcification Medical Policy Section Radiology Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013

More information

Adapted Transfer Function Design for Coronary Artery Evaluation

Adapted Transfer Function Design for Coronary Artery Evaluation Adapted Transfer Function Design for Coronary Artery Evaluation Sylvia Glaßer 1, Steffen Oeltze 1, Anja Hennemuth 2, Skadi Wilhelmsen 3, Bernhard Preim 1 1 Department of Simulation and Graphics, University

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor of Medicine and Imaging Cedars-Sinai

More information

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 n&list_uids=17433949 64-Multislice Detector Computed Tomography Coronary Angiography as Potential Alternative

More information

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million

More information

Who Cares About the Past?

Who Cares About the Past? Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring

More information

A Rosetta Stone for Coronary Calcium Risk Stratification: Agatston, Volume, and Mass Scores in 11,490 Individuals

A Rosetta Stone for Coronary Calcium Risk Stratification: Agatston, Volume, and Mass Scores in 11,490 Individuals Downloaded from www.ajronline.org by 46.3.206.24 on 0/2/8 from IP address 46.3.206.24. Copyright ARRS. For personal use only; all rights reserved John A. Rumberger Leon Kaufman 2,3 Received January, 2003;

More information

Risk Stratification for CAD for the Primary Care Provider

Risk Stratification for CAD for the Primary Care Provider Risk Stratification for CAD for the Primary Care Provider Shimoli Shah MD Assistant Professor of Medicine Directory, Ambulatory Cardiology Clinic Knight Cardiovascular Institute Oregon Health & Sciences

More information

Current and Future Imaging Trends in Risk Stratification for CAD

Current and Future Imaging Trends in Risk Stratification for CAD Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction

More information

ACCF/AHA Expert Consensus Document

ACCF/AHA Expert Consensus Document ACCF/AHA Expert Consensus Document ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation

More information

Repeatability Limits for Measurement of Coronary Artery Calcified Plaque with Cardiac CT in the Multi-Ethnic Study of Atherosclerosis

Repeatability Limits for Measurement of Coronary Artery Calcified Plaque with Cardiac CT in the Multi-Ethnic Study of Atherosclerosis Cardiac Imaging Original Research Chung et al. CT of Coronary Artery Plaque Cardiac Imaging Original Research Hyoju Chung 1 Robyn L. McClelland 1 Ronit Katz 1 J. Jeffrey Carr 2 Matthew J. Budoff 3 Chung

More information

Imaging Atheroma The quest for the Vulnerable Plaque

Imaging Atheroma The quest for the Vulnerable Plaque Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing

More information

RAMA-EGAT Risk Score for Predicting Coronary Artery Disease Evaluated by 64- Slice CT Angiography

RAMA-EGAT Risk Score for Predicting Coronary Artery Disease Evaluated by 64- Slice CT Angiography RAMA-EGAT Risk Score for Predicting Coronary Artery Disease Evaluated by 64- Slice CT Angiography Supalerk Pattanaprichakul, MD 1, Sutipong Jongjirasiri, MD 2, Sukit Yamwong, MD 1, Jiraporn Laothammatas,

More information

CARDIAC IMAGING FOR SUBCLINICAL CAD

CARDIAC IMAGING FOR SUBCLINICAL CAD CARDIAC IMAGING FOR SUBCLINICAL CAD WHY DON'T YOU ADOPT MORE SMART TECHNIQUE? Whal Lee, M.D. Seoul National University Hospital Department of Radiology We are talking about Coronary artery Calcium scoring,

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Diabetes and Occult Coronary Artery Disease

Diabetes and Occult Coronary Artery Disease Diabetes and Occult Coronary Artery Disease Mun K. Hong, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory & Interventional Cardiology St. Luke s-roosevelt Hospital Center New York, New York

More information

ORIGINAL INVESTIGATION. Electron-Beam Computed Tomography in the Diagnosis of Coronary Artery Disease

ORIGINAL INVESTIGATION. Electron-Beam Computed Tomography in the Diagnosis of Coronary Artery Disease Electron-Beam Computed Tomography in the Diagnosis of Coronary Artery Disease A Meta-analysis ORIGINAL INVESTIGATION Brahmajee K. Nallamothu, MD, MPH; Sanjay Saint, MD, MPH; Lawrence F. Bielak, DDS, MPH;

More information

Of the 1.5 million heart attacks

Of the 1.5 million heart attacks CARDIOLOGY PATIENT PAGE CARDIOLOGY PATIENT PAGE C-Reactive Protein A Simple Test to Help Predict Risk of Heart Attack and Stroke Paul M Ridker, MD, MPH Of the 1.5 million heart attacks and 600 000 strokes

More information

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet? Evolving Role of Coronary CTA in Primary Cardiovascular Disease Prevention: Are We There Yet? Ron Blankstein, M.D., F.A.C.C. Co-Director, Cardiovascular Imaging Training Program Associate Physician, Preventive

More information

Data Alert. Vascular Biology Working Group. Blunting the atherosclerotic process in patients with coronary artery disease.

Data Alert. Vascular Biology Working Group. Blunting the atherosclerotic process in patients with coronary artery disease. 1994--4 Vascular Biology Working Group www.vbwg.org c/o Medical Education Consultants, LLC 25 Sylvan Road South, Westport, CT 688 Chairman: Carl J. Pepine, MD Eminent Scholar American Heart Association

More information

Journal of the American College of Cardiology Vol. 49, No. 3, by the American College of Cardiology Foundation ISSN /07/$32.

Journal of the American College of Cardiology Vol. 49, No. 3, by the American College of Cardiology Foundation ISSN /07/$32. Journal of the American College of Cardiology Vol. 49, No. 3, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.10.001

More information

Coronary calcification detected by electron-beam computed tomography and myocardial infarction

Coronary calcification detected by electron-beam computed tomography and myocardial infarction European Heart Journal (2002) 23, 1596 1603 doi:10.1053/euhj.2002.3240, available online at http://www.idealibrary.com on Coronary calcification detected by electron-beam computed tomography and myocardial

More information

Identifying patients at risk: novel diagnostic techniques

Identifying patients at risk: novel diagnostic techniques European Heart Journal Supplements (2004) 6 (Supplement C), C15 C20 Identifying patients at risk: novel diagnostic techniques Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, OH, USA

More information

Perspectives of new imaging techniques for patients with known or suspected coronary artery disease

Perspectives of new imaging techniques for patients with known or suspected coronary artery disease Perspectives of new imaging techniques for patients with known or suspected coronary artery disease Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands Correspondence: Jeroen

More information

Summary. Cyprian Wolski, Arkadiusz Rotkiewicz, Piotr Grzelak, Marcin Elgalal, Ludomir Stefańczyk. Background

Summary. Cyprian Wolski, Arkadiusz Rotkiewicz, Piotr Grzelak, Marcin Elgalal, Ludomir Stefańczyk. Background Signature: Pol J Radiol, 2011; 76(4): 15-20 ORIGINAL ARTICLE Received: 2010.11.24 Accepted: 2011.08.16 Comparison of tomographic coronary artery calcification index (calcium score) and ultrasonographic

More information

Despite a significant reduction in coronary artery disease

Despite a significant reduction in coronary artery disease Clinical Investigation and Reports Identification of Patients at Increased Risk of First Unheralded Acute Myocardial Infarction by Electron-Beam Computed Tomography Paolo Raggi, MD; Tracy Q. Callister,

More information

Section: Radiology Last Reviewed Date: December Policy No: 6 Effective Date: February 1, 2014

Section: Radiology Last Reviewed Date: December Policy No: 6 Effective Date: February 1, 2014 Medical Policy Manual Topic: Computed Tomography to Detect Coronary Artery Calcification Date of Origin: January 1996 Section: Radiology Last Reviewed Date: December 2013 Policy No: 6 Effective Date: February

More information

I have no financial disclosures

I have no financial disclosures Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic

More information

Medical Policy. Medical Policy. MP Computed Tomography to Detect Coronary Artery Calcification

Medical Policy. Medical Policy. MP Computed Tomography to Detect Coronary Artery Calcification Medical Policy Medical Policy MP 6.01.03 BCBSA Ref. Policy: 6.01.03 Last Review: 09/28/2017 Effective Date: 09/28/2017 Section: Medicine Related Policies 6.01.43 Contrast-Enhanced Computed Tomography Angiography

More information

Potential recommendations for CT coronary angiography in athletes

Potential recommendations for CT coronary angiography in athletes Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

CT Coronary Angiography - Indications: From the guidelines to clinical practice

CT Coronary Angiography - Indications: From the guidelines to clinical practice CT Coronary Angiography - Indications: From the guidelines to clinical practice Multimodality Working Group of Cardiovascular Imaging (Nuc C, CCT CMR) Hellenic Cardiology Society Seminars, Thessaloniki,

More information

BENEFIT APPLICATION BLUECARD/NATIONAL ACCOUNT ISSUES

BENEFIT APPLICATION BLUECARD/NATIONAL ACCOUNT ISSUES Medical Policy Medical Policy MP 6.01.03 BCBSA Ref. Policy: 6.01.03 Last Review: 09/19/2018 Effective Date: 09/19/2018 Section: Medicine Related Policies 9.01.502 Experimental / Investigational Services

More information

The term syndrome X, first raised by Kemp et al 1

The term syndrome X, first raised by Kemp et al 1 Differential Coronary Calcification on Electron-Beam CT Between Syndrome X and Coronary Artery Disease in Patients With Chronic Stable Angina Pectoris* Lung-Ching Chen, MD; Jaw-Wen Chen, MD; Mei-Han Wu,

More information

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively

More information

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging Imaging the Vulnerable Plaque David A. Dowe, MD Atlantic Medical Imaging Why is this so important? The Acute Situation Coronary disease-important Diagnosis of cardiovascular disease cost $148 billion in

More information

Patient referral for elective coronary angiography: challenging the current strategy

Patient referral for elective coronary angiography: challenging the current strategy Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology

More information

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Computed Tomography to Detect Coronary Artery Calcification Page 1 of 9 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: See also: Computed Tomography (CT) to

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Coronary Artery Imaging Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Larger array : cover scan area Detector size : spatial resolution Rotation speed : scan time Retrospective

More information

The Coronary Artery Calcium Score and Stress Myocardial Perfusion Imaging Provide Independent and Complementary Prediction of Cardiac Risk

The Coronary Artery Calcium Score and Stress Myocardial Perfusion Imaging Provide Independent and Complementary Prediction of Cardiac Risk Journal of the American College of Cardiology Vol. 54, No. 20, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.05.071

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

MD F A F C A C MAS A N S C

MD F A F C A C MAS A N S C Myocardial Perfusion Imaging and Coronary Calcium Scoring: Complimentary or Competitive David Wolinsky MD FACC MASNC Section Head Nuclear Cardiology, Cleveland Clinic Florida Immediate Past President,

More information

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA

More information